PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 48 filers reported holding PAIN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $628,000 | -56.9% | 628,425 | -5.6% | 0.00% | -100.0% |
Q2 2016 | $1,458,000 | -1.8% | 665,780 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,485,000 | +27.5% | 665,780 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,165,000 | -10.0% | 665,780 | -5.9% | 0.00% | 0.0% |
Q3 2015 | $1,295,000 | +3.7% | 707,480 | -2.0% | 0.00% | 0.0% |
Q2 2015 | $1,249,000 | -14.3% | 721,921 | -6.3% | 0.00% | 0.0% |
Q1 2015 | $1,457,000 | -6.8% | 770,678 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,564,000 | -48.5% | 770,678 | -0.8% | 0.00% | -50.0% |
Q3 2014 | $3,038,000 | -30.7% | 776,990 | +2.0% | 0.00% | -33.3% |
Q2 2014 | $4,381,000 | +29.7% | 761,998 | +24.0% | 0.00% | 0.0% |
Q1 2014 | $3,379,000 | +23.7% | 614,405 | +9.3% | 0.00% | +50.0% |
Q4 2013 | $2,732,000 | +68.0% | 562,218 | -6.0% | 0.00% | +100.0% |
Q3 2013 | $1,626,000 | +6.6% | 597,978 | -13.4% | 0.00% | 0.0% |
Q2 2013 | $1,526,000 | – | 690,649 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |